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www.sciencemag.org/content/343/6166/66/suppl/DC1 Materials and Methods Figs. S1 to S8 Table S1 Movie S1 References (23- The Y chromosome is thought to be important for male reproduction. We have previously shown that, with the use of assisted reproduction, live offspring can be obtained from mice lacking the entire Y chromosome long arm. Here, we demonstrate that live mouse progeny can also be generated by using germ cells from males with the Y chromosome contribution limited to only two genes, the testis determinant factor Sry and the spermatogonial proliferation factor Eif2s3y. Sry is believed to function primarily in sex determination during fetal life. Eif2s3y may be the only Y chromosome gene required to drive mouse spermatogenesis, allowing formation of haploid germ cells that are functional in assisted reproduction. Our findings are relevant, but not directly translatable, to human male infertility cases.
T he mammalian Y chromosome, once thought to be a genetic wasteland (1) , is now known to encode a battery of genes, many of which are thought to be involved in male reproduction (2) . A substantial amount of work has been done to define which genes are important for maintaining sperm function under normal, in vivo, conditions. In the era of assisted reproduction technologies (ART), it is now possible to bypass several steps of normal human fertilization using immotile, nonviable, or even immature sperm. We have shown that infertile male mice lacking the entire Y chromosome long arm can generate live offspring when their severely morphologically abnormal sperm are delivered into oocytes via intracytoplasmic sperm injection (ICSI) (3). In these mice, the Y chromosome is reduced from 78 Mb to~2 Mb and encodes only seven genes and three gene families (XY* X Sxr a in fig. S1 ). In most mammals, including humans and mice, testis determination is regulated by Sry, which directs developing gonads to male differentiation (4) (5) (6) . Upon transgenic addition of Sry, mice with one X chromosome (XOSry) develop testes that are populated with spermatogonia, male germ cells that have the potential to undergo differentiation and initiate spermatogenesis. In the absence of other Y chromosome genes, these spermatogonia undergo proliferation arrest, and the meiotic and postmeiotic stages of spermatogenesis are absent (7) . Transgenic addition of individual missing Y genes led to the identification of Eif2s3y as the gene that restored normal spermatogonial proliferation (7) . In XOSry males transgenic for Eif2s3y, spermatogenesis was shown to complete meiotic prophase and the first meiotic division before the cells arrested as secondary spermatocytes, with the occasional production of spermatid-like cells (7, 8) . Here, we tested whether these spermatid-like cells were functional in assisted reproduction and what other components of the Y chromosome help to increase development of functional gametes.
We first examined mice with the Y gene complement limited to two transgenically derived genes, autosomally located Sry and X chromosome located Eif2s3y (X E OSry in fig. S1 ) (9) . These mice had testes smaller than wild-type XY males ( fig. S2 ) but populated with germ cells. Analysis of testicular sections confirmed that spermatogenesis was ongoing, which allowed development of germ cells with spermatid-like morphology (Fig. 1A, arrowheads) , similar to those observed earlier (7, 10) . The occurrence of these spermatids was low, and their development was restricted to steps 5 to 7 of spermatid development, with the occasional presence of step 8 to 9 spermatids [ Fig. 1A (inset) and fig. S3 ]. We also observed secondary changes to seminiferous tubules, with increased incidence of dying cells, multinucleate bodies, and vacuoles (Fig. 1B) . These changes increased progressively as the males aged and ultimately led to Sertoli-cell-only (SCO) syndrome tubules (Fig. 1C) .
We next tested the function of the spermatidlike cells from X E OSry in assisted reproduction. Round, spermatid-like cells could be found in testicular cell suspensions from all males used in ART trials, although these cells were rare and their morphology was often slightly abnormal (increased size, less pronounced nuclei, and rough rather than smooth surface) when compared with spermatids from control XY males (Fig. 1, D and E). Nevertheless, when we performed round spermatid injection (ROSI), the oocytes were successfully fertilized, as evidenced by the development of two pronuclei and extrusion of the second polar body, as well as subsequent cleavage ( fig. S4 ). When the developed two-cell embryos were transferred into the oviducts of recipient females, live offspring were obtained (Table 1 and Fig. 1F ). Three out of four males that provided spermatids for injections successfully sired offspring. The efficiency of ROSI with X E OSry males was significantly lower than with XY controls (9% versus 26%) ( Table 1 ). All the progeny had the genotypes as expected when derived from X E OSry fathers and were healthy; those bred were fertile (Fig. 1G, fig. S5 , and supplementary text).
An unpaired sex chromosome leads to meiotic arrest and apoptosis (11) , so partial meiotic failure in X E OSry males was not unexpected. The few spermatids that could be found in the testes could be the cells that "leaked" through the meiotic arrest, i.e., finished meiosis and were haploid. Alternatively, these could be the cells that developed spermatid-like morphology without undergoing the second meiotic division (8, 10). (Fig. 3 ) revealed that the great majority of spermatids from X E OSry males were diploid and yielded triploid zygotes, which would explain the poor ROSI success. In order to overcome the problem of meiotic block arising from X chromosome univalence, we used males in which a minute Y* X chromosome ( fig. S1 ) was added to provide a second pairing region (PAR) for PAR-PAR chromosome synapsis (12) . In these X E Y* X Sry males ( fig. S1 ), successful pairing of Y* X and X was observed in 85% of pachytene spermatocytes ( fig. S8 ). However, the testicular phenotype did not improve (figs. S2 and S7, A to C). The proportion of live offspring obtained after injection was similarly low as with X E OSry males (Table 1) , and only five out of eight males that provided cells for ROSI sired offspring. We therefore tested for ploidy and demonstrated that most of the X E Y* X Sry spermatids were diploid ( Fig. 2  and fig. S6 ) and that most zygotes after ROSI were triploid (Fig. 3) . Thus, overcoming X chromosome univalence in X E Y* X Sry males did not allow overcoming meiotic arrest and increasing ROSI success (see supplementary text).
We next asked whether other Y chromosome genes may be beneficial for spermatid function in assisted reproduction. To address this, we used males in which the Sry transgene driving sex determination was replaced with the sex reversal factor Sxr fig. S1 ). In these males, the X chromosome carries an Eif2s3y transgene necessary for spermatogonial proliferation (7), together with the Sxr b encoding for Zfy2/1, Sry, H2al2y, and the Rbmy gene cluster. S3 ). Scale bars, 16 mm (A and B), 50 mm (C), and 10 mm (D and E); inset, ×3 magnification; mo, months of age. X males less pronounced than in the other genotypes. Zygote chromosome analysis showed that most of the zygotes after ROSI were diploid (71 to 85%) (Fig. 3) , and the ROSI outcome was significantly improved, with all tested males (three per genotype) yielding live offspring with the rate now reaching 20 and 16% (Table 1) . Nevertheless, the frequency of haploid spermatids in X E Sxr b O males remained low (Fig.  2 and fig. S6 ). The discrepancy between the ploidy of the spermatids and zygotes raised the possibility that the second meiotic division took place in the oocytes. This suggests that Sxr b encodes a gene or genes that promote the second meiotic division when all chromosomes are paired and enables overcoming of meiotic arrest of the diploid spermatid in the oocyte when an X chromosome pairing partner is missing (see supplementary text).
We have shown that only two mouse Y chromosome genes, Sry and Eif2s3y, are necessary for the development of male haploid germ cells that are sufficient for successful reproduction and yield live offspring. This minimal Y gene complement must be enough to ensure correct male-specific methylation and proper formation of any other epigenetic modifications in the paternal genome that are required for embryogenesis.
That Sry is one of the two genes is not surprising, as it drives testis determination (4-6). Mouse Sry expression and translation occur very briefly during fetal development. In adult testes, Sry transcripts are thought to be aberrant and not translatable (13, 14) , although their role as epigenetic regulator(s) cannot be excluded (15) . Nevertheless, it is reasonable to conclude that Sry plays a role primarily during sex determination.
This suggests that the second Y gene, Eif2s3y, is the only gene necessary to drive spermatogenesis through the first meiotic division and with the occasional meiotic progression to form haploid round spermatids. Eif2s3y is a Y-encoded subunit 3 of the eukaryotic translation initiation factor 2. It is ubiquitously expressed and, in the testis, plays a role in spermatogonial proliferation (7) . The Eif2s3y gene has been conserved on the Y chromosome during eutherian evolution, but there is no Y-linked copy of Eif2s3 detected in any of the simian primates, including humans (16) .
In men, spermatogonial proliferation arrest results most often from deletions of AZFa (azoospermia; SCO syndrome), and it has been related to a loss of DDX3Y (17) (18) (19) . In both men and mice, the Eif2s3 and Ddx3 genes belong to the family of widely expressed genes encoding proteins involved in initiation of mRNA translation at the ribosome. These genes have X homologs that escape X-inactivation, and the Y and X copies are suspected to be, at least in part, interchangeable, with the Y copy conserved to provide two doses of gene product in both male and female. The loss of the mouse Y-encoded Ddx3y is not detrimental for spermatogenesis because of the compensation provided by an X copy retrotransposed on an autosome (20) . Analogically, in men, the presence of a retrotransposed X copy of EIF2S3X, in addition to EIF2S3X itself, explains why the loss of the Y copy was still permissive for spermatogenesis. Although there is no human copy of Eif2s3y, men have a Y-encoded copy of the translation factor EIF1A (eukaryotic translation initiation factor 1A, Y-linked) (21) , which likely acts as part of a multiprotein complex that includes EIF2S3X, as well as other EIF family members. Note that EIF1AY is found in the AZFb region, and its diminished expression sporadically contributes to azoospermia (22) .
At present, our findings in mice do not translate directly to humans. ROSI is still considered experimental in human ART because of concerns regarding the safety of injecting immature germ cells and technical difficulties (23) . In spite of this, some children have already been born (24, 25) , and those were healthy. As we learn more about the effects and improve technical aspects of ROSI, this method may become more acceptable. Indeed, studies on ROSI effects in mice have been encouraging (26) . Thus, our study may bear importance for clinicians working in ART clinics by supporting the possibility that ROSI may be a viable option for overcoming infertility in men with nonobstructive azoospermia.
Considering that we have obtained live offspring using germ cells from males with only two Y chromosome genes, one could question the importance of the Y chromosome in male reproduction. We believe that the answer lies in defining the need. Human Y chromosome is not on the way to oblivion, as has been implied in the past (27) , and its genetic information is undoubtedly important for many aspects of reproduction involving the development of mature sperm and its function in normal fertilization (28) . Most of the mouse Y chromosome genes are involved in spermatogenesis and sperm function and, as such, are necessary for normal fertilization (29, 30) . However, when it comes to assisted reproduction, our mouse study proves that the Y chromosome contribution can be brought to a bare minimum consisting of Sry and Eif2s3y. Indeed, it may well be possible to eliminate mouse Y chromosome altogether if appropriate replacements are made for those two genes. In glioblastoma (GBM), the most common malignant primary brain cancer of adults, the epidermal growth factor receptor (EGFR) is frequently mutated, commonly giving rise to the constitutively active oncogenic variant EGFRvIII (4, 5) . EGFRvIII potently accelerates tumor growth by cell-autonomous and intercellular signaling mechanisms (6) , but it also makes tumor cells that express it more sensitive to EGFR tyrosine kinase inhibitors (TKIs) (7, 8) . In clinical GBM samples, the level of EGFRvIII protein expression varies widely among cells within the tumor mass (6, 9-15). The potential contribution of heterogeneous EGFRvIII expression to EGFR TKI resistance in GBM (16) ) demonstrated increased phosphatidylinositol 3-kinase-Akt-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling (Fig. 1A and fig. S2 ), elevation in tumor cell proliferation by a factor of 4 ( Fig. 1B and fig. S2 ), a lower basal apoptotic rate by a factor of 15 ( Fig.  1C and fig. S2 ), and increased glucose uptake (Fig. 1D) relative to the GBM cells lacking detectable EGFRvIII protein (EGFRvIII Low ) (Fig.  1, D and E) . Further, the EGFRvIII High tumor cells showed enhanced cell death in response to the EGFR TKI erlotinib (Fig. 1F) .
To determine the effect of an EGFR TKI on EGFRvIII population dynamics, mice bearing tumors were treated daily with oral erlotinib (150 mg per kg of weight). Erlotinib treatment initially caused 80% tumor shrinkage (response) (blue line in Fig. 1G ), shifting the composition of tumors from being predominantly EGFRvIII High to predominantly EGFRvIII Low tumor cells (Fig.  1H and fig. S3 ). This shift in the EGFRvIII population dynamics was maintained, even after tumors developed resistance to continued erlotinib treatment (resistant) [ Fig. 1G (red line) and H, and fig. S3 ], and was also detected in another patientderived ex vivo neurosphere culture, HK296 ( fig.  S4 ). Most important, in tumor tissue from GBM patients treated for 7 to 10 days with the EGFR/ HER2 inhibitor lapatinib, the relative fraction of EGFRvIII High tumor cells dramatically declined relative to each patient's pretreatment sample (Fig.  1, I and J). Of note, this analysis was confined to patients whose posttreatment tumor tissue showed reduced EGFR phosphorylation relative to the pretreatment sample. We did not detect any decrease in EGFRvIII level in the two available GBMs in which no decrease in phospho-EGFR was seen after lapatinib treatment.
